Gi bn tham kho: 600.000 VN/hp/60 vin
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
Sold Out Protect your skin, stimulate cell regeneration and enhance your metabolism with Altrient Glutathione
Seven additional Phase 3 trials are expected to report results in 2026
Peptides can alter the potency of other agents
United States import requirements Importing research peptides into the United States requires clear documentation establishing the material as research-use-only